[Broker Focus] BOC International indicates that it has issued documents in many places to support the high-quality development of innovative pharmaceutical devices and recommend investment opportunities in the biomedical industry chain

Jinwu Financial News | BOC International said that documents have been issued in many places to support the high-quality development of the biomedical industry. Beijing emphasized separate payments for innovative drugs, while Guangzhou and Zhuhai provided strong financial support. The biotech sector rose 3.9% this week, ranking first among all pharmaceutical sub-sectors. The bank is optimistic about the long-term development prospects of the innovative drug industry, and continues to promote innovative pharmaceutical companies with differentiated products, an international layout, and rich and important data readout/important regulatory approval catalysts during the year, including Kangfang Biotech and Xiansheng Pharmaceutical. Entering the second quarter, the bank suggests focusing on the performance of A-share and US pharmaceutical companies' annual/quarterly reports, as well as important

金吾財訊Apr 9 21:08 ET

Hangzhou Tigermed Consulting Reports FY Results

Seeking AlphaMar 28 09:42 ET

2024 Financial Report | BGI's profit fell by more than 80%, making it difficult to find the next outlet

The era of gold everywhere is over

wallstreetcnFeb 29 23:48 ET

Is the healthcare market recovering? Mindray Healthcare acquires control of Whitney Healthcare at 25% premium | Insight Research

In the new year, A was born, and the leading device company Mindray entered the cardiovascular field at a premium.

wallstreetcnJan 28 18:56 ET

Zheshang Securities: In the context of increasing certainty in pharmaceutical demand and increasing health insurance supervision, it is optimistic about the rising trend of the boom in innovative pharmaceutical devices

As healthcare reform continues to deepen, it is recommended to focus on the CXO sector, which is driven by demand in the industrial chain, compounded by policy immunization and weight reduction.

Zhitong FinanceOct 13, 2023 01:43 ET

Zheshang Securities: Two factors drive the upward trend in the boom in innovative pharmaceutical devices, and the CXO sector's performance differentiation continues

Zheshang Securities released a research report stating that it is optimistic about the trend of increasing the boom in innovative pharmaceutical devices against the backdrop of increased certainty in demand for pharmaceuticals and increased health insurance supervision.

Zhitong FinanceOct 12, 2023 19:12 ET